Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Metagenomi Therapeutics, Inc. | 42,000 | reported | 02 Sept 2025 | tx 1+42,000 |
| ALNYLAM PHARMACEUTICALS, INC. | 18,103 | reported | 31 Dec 2014 | tx 54+590,689−183,082 |
| KalVista Pharmaceuticals, Inc. | 17,000 | reported | 23 Nov 2024 | tx 1+17,000 |
| Decibel Therapeutics, Inc. | 0 | reported | 25 Sept 2023 | tx 8+464,500−1,552,888 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Sept 2025 | GRANT_AWARD | Metagenomi Therapeutics, Inc. | 42,000 | 0.00 USD | deriv |
| 23 Nov 2024 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 17,000 | 0.00 USD | deriv |
| 25 Sept 2023 | OTHER | Decibel Therapeutics, Inc. | 220,849 | — | |
| 25 Sept 2023 | OTHER | Decibel Therapeutics, Inc. | 1,072,539 | — | deriv |
| 25 Sept 2023 | OTHER | Decibel Therapeutics, Inc. | 187,500 | — | deriv |
| 25 Sept 2023 | OTHER | Decibel Therapeutics, Inc. | 72,000 | — | deriv |
| 16 Mar 2023 | GRANT_AWARD | Decibel Therapeutics, Inc. | 195,000 | 0.00 USD | |
| 16 Mar 2023 | GRANT_AWARD | Decibel Therapeutics, Inc. | 72,000 | 0.00 USD | deriv |
| 25 Feb 2022 | GRANT_AWARD | Decibel Therapeutics, Inc. | 187,500 | 0.00 USD | deriv |
| 15 Sept 2021 | PURCHASE | Decibel Therapeutics, Inc. | 10,000 | 7.64 USD | first after silence |
| 31 Dec 2014 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 17,000 | 15.99 USD | |
| 31 Dec 2014 | TAX_WITHHOLDING | ALNYLAM PHARMACEUTICALS, INC. | 2,802 | 97.00 USD | |
| 31 Dec 2014 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 17,000 | 0.00 USD | deriv |
| 12 Dec 2014 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 6,667 | 0.00 USD | deriv |
| 18 Nov 2014 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 2,500 | 7.10 USD | |
| 18 Nov 2014 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 3,861 | 9.14 USD | |
| 18 Nov 2014 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 102 | 91.79 USD | anomaly |
| 18 Nov 2014 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 5,413 | 90.30 USD | |
| 18 Nov 2014 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 4,485 | 91.08 USD | |
| 18 Nov 2014 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 3,639 | 15.99 USD | |
| 18 Nov 2014 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 3,861 | 0.00 USD | deriv |
| 18 Nov 2014 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 2,500 | 0.00 USD | deriv |
| 18 Nov 2014 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 3,639 | 0.00 USD | deriv |
| 18 Aug 2014 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 11,000 | 9.14 USD | |
| 18 Aug 2014 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 7,000 | 67.80 USD |
1 purchase reported after at least 12 months of silence — most recent on 15 Sept 2021.